Bioremediation of industrial pharmaceutical drugs.
Recently, attention has been drawn toward the occurrence of pharmaceuticals in the environment. In recent years, many reports have been made on the occurrence of the large, differentiated group of pharmaceuticals in wastewater (PW), surface water, ground water, and in soil. The pharmaceutical sector is currently expanding in Tunisia, with more than 34 industries. The aim of this work was to evaluate the ability of Pseudomonas putida mt-2 to treat PW. P. putida was very efficient in reducing chemical oxygen demand (COD), total dissolved solids (TDS), and turbidity of solution (85.5, 89.1, and 81.5%, respectively). Genotoxicity of effluent, before and after biodegradation, was evaluated in vivo in mouse bone marrow by assessing the percentage of cells bearing different chromosome aberrations. Results indicated that PW showed a significant ability to induce DNA damage. In addition, PW induced a remarkable lipid peroxidation (LPO) effect, however, activities of both acetylcholinesterase (AChE) and butyrylcholinesterase (BuChE) were unchanged when treated with PW, compared to nontreated PW. This toxicity was imputed to the presence of pharmaceutical compounds in wastewater. However, chromosome aberration, as well as LPO of PW, were significantly reduced after bioremediation. Thus, the use of this strain for testing on the industrial scale seems possible and advantageous.
Laboratoire de Biologie Cellulaire et Moléculaire, Faculté de Médecine Dentaire, Monastir, Tunisie.
Hedi Ben
HB
Mansour
Ridha
R
Mosrati
Daniel
D
Barillier
Kamel
K
Ghedira
Leila
L
Chekir-Ghedira
D000818:Animals; D001673:Biodegradation, Environmental; D057919:Biological Oxygen Demand Analysis; D001854:Bone Marrow Cells / Q000187:drug effects; D002869:Chromosome Aberrations / Q000187:drug effects; D015227:Lipid Peroxidation / Q000187:drug effects; D051379:Mice; D009391:Nephelometry and Turbidimetry; D004364:Pharmaceutical Preparations / Q000032:analysis / Q000378:metabolism*; D016958:Pseudomonas putida / Q000378:metabolism*; D014416:Tunisia; D014874:Water Pollutants, Chemical / Q000032:analysis / Q000378:metabolism* / Q000633:toxicity*
D004364:Pharmaceutical Preparations; D014874:Water Pollutants, Chemical